Literature DB >> 20599476

Sphingomyelin accumulation provides a favorable milieu for GM1 ganglioside-induced assembly of amyloid beta-protein.

Kohei Yuyama1, Katsuhiko Yanagisawa.   

Abstract

The assembly of amyloid beta-protein into fibrils is an initial event of Alzheimer's disease (AD). Previous studies suggest that ganglioside-bound amyloid beta-protein (Abeta), GAbeta, is an endogenous seed for amyloid in Alzheimer's disease (AD) brain and that GAbeta is generated in the membrane microdomains, comprising cholesterol, sphingomyelin (SM) and GM1 ganglioside. In this study, we showed that the GAbeta-dependent amyloidogenesis was accelerated on the surface of PC12 cells that had been pretreated with a sphingomyelinase inhibitor. Conversely, the enhanced GAbeta-dependent amyloidogenesis under the endocytic dysfunction, which is one of the cell-pathological features of AD, was suppressed by pretreatment with a SM synthase inhibitor. These suggest that SM is one of the key molecules for GAbeta generation and further imply that the interaction of Abeta with membrane lipids is critical in amyloid fibrillization in the brain. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599476     DOI: 10.1016/j.neulet.2010.06.080

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

Review 1.  Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles.

Authors:  Claudia Verderio; Martina Gabrielli; Paola Giussani
Journal:  J Lipid Res       Date:  2018-05-31       Impact factor: 5.922

Review 2.  GM1 ganglioside and Alzheimer's disease.

Authors:  Katsuhiko Yanagisawa
Journal:  Glycoconj J       Date:  2015-04-23       Impact factor: 2.916

Review 3.  Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseases.

Authors:  Sara Grassi; Paola Giussani; Laura Mauri; Simona Prioni; Sandro Sonnino; Alessandro Prinetti
Journal:  J Lipid Res       Date:  2019-12-23       Impact factor: 5.922

4.  Decreased amyloid-β pathologies by intracerebral loading of glycosphingolipid-enriched exosomes in Alzheimer model mice.

Authors:  Kohei Yuyama; Hui Sun; Shota Sakai; Susumu Mitsutake; Megumi Okada; Hidetoshi Tahara; Jun-Ichi Furukawa; Naoki Fujitani; Yasuro Shinohara; Yasuyuki Igarashi
Journal:  J Biol Chem       Date:  2014-07-18       Impact factor: 5.157

5.  Upregulated function of mitochondria-associated ER membranes in Alzheimer disease.

Authors:  Estela Area-Gomez; Maria Del Carmen Lara Castillo; Marc D Tambini; Cristina Guardia-Laguarta; Ad J C de Groof; Moneek Madra; Junichi Ikenouchi; Masato Umeda; Thomas D Bird; Stephen L Sturley; Eric A Schon
Journal:  EMBO J       Date:  2012-08-14       Impact factor: 11.598

6.  The pathological roles of ganglioside metabolism in Alzheimer's disease: effects of gangliosides on neurogenesis.

Authors:  Toshio Ariga; Chandramohan Wakade; Robert K Yu
Journal:  Int J Alzheimers Dis       Date:  2011-01-09

7.  Imbalance in fatty-acid-chain length of gangliosides triggers Alzheimer amyloid deposition in the precuneus.

Authors:  Naoto Oikawa; Teruhiko Matsubara; Ryoto Fukuda; Hanaki Yasumori; Hiroyuki Hatsuta; Shigeo Murayama; Toshinori Sato; Akemi Suzuki; Katsuhiko Yanagisawa
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

Review 8.  Alzheimer's Disease: Mechanism and Approach to Cell Therapy.

Authors:  Takashi Amemori; Pavla Jendelova; Jiri Ruzicka; Lucia Machova Urdzikova; Eva Sykova
Journal:  Int J Mol Sci       Date:  2015-11-04       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.